...
search icon
bolt-img

Bolt Biotherapeutics, Common Stock

BOLT

NAQ

$0.412

-$0.02

(-4.59%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$16.19M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
72.95K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.94
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.42 L
$1.56 H
$0.412

About Bolt Biotherapeutics, Common Stock

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameBOLTSectorS&P500
1-Week Return-6.72%-0.2%-1.38%
1-Month Return-11.4%2.04%-4.79%
3-Month Return-27.86%3.59%-4.48%
6-Month Return-34.84%-4.15%5%
1-Year Return-67.56%2%12.66%
3-Year Return-86.62%14.91%35.37%
5-Year Return-98.72%56.71%100.72%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue215.00K231.00K1.26M5.73M7.88M[{"date":"2019-12-31","value":2.73,"profit":true},{"date":"2020-12-31","value":2.93,"profit":true},{"date":"2021-12-31","value":16,"profit":true},{"date":"2022-12-31","value":72.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue26.00M40.36M3.67M4.89M1.88M[{"date":"2019-12-31","value":64.43,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":9.1,"profit":true},{"date":"2022-12-31","value":12.12,"profit":true},{"date":"2023-12-31","value":4.67,"profit":true}]
Gross Profit(25.79M)(40.13M)(2.41M)838.00K5.99M[{"date":"2019-12-31","value":-430.36,"profit":false},{"date":"2020-12-31","value":-669.66,"profit":false},{"date":"2021-12-31","value":-40.25,"profit":false},{"date":"2022-12-31","value":13.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin(11993.95%)(17370.56%)(191.43%)14.63%76.08%[{"date":"2019-12-31","value":-15765.08,"profit":false},{"date":"2020-12-31","value":-22832.2,"profit":false},{"date":"2021-12-31","value":-251.62,"profit":false},{"date":"2022-12-31","value":19.23,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses31.18M49.41M94.05M96.05M84.07M[{"date":"2019-12-31","value":32.47,"profit":true},{"date":"2020-12-31","value":51.45,"profit":true},{"date":"2021-12-31","value":97.92,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":87.53,"profit":true}]
Operating Income(30.97M)(49.18M)(92.79M)(90.32M)(76.20M)[{"date":"2019-12-31","value":-3096900000,"profit":false},{"date":"2020-12-31","value":-4918200000,"profit":false},{"date":"2021-12-31","value":-9278800000,"profit":false},{"date":"2022-12-31","value":-9032100000,"profit":false},{"date":"2023-12-31","value":-7619600000,"profit":false}]
Total Non-Operating Income/Expense1.01M(11.35M)(5.52M)4.45M13.18M[{"date":"2019-12-31","value":7.63,"profit":true},{"date":"2020-12-31","value":-86.11,"profit":false},{"date":"2021-12-31","value":-41.9,"profit":false},{"date":"2022-12-31","value":33.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(30.49M)(60.73M)(98.59M)(88.10M)(69.20M)[{"date":"2019-12-31","value":-3048700000,"profit":false},{"date":"2020-12-31","value":-6072800000,"profit":false},{"date":"2021-12-31","value":-9859100000,"profit":false},{"date":"2022-12-31","value":-8809800000,"profit":false},{"date":"2023-12-31","value":-6919700000,"profit":false}]
Income Taxes(482.00K)11.55M5.80M(2.22M)1.72M[{"date":"2019-12-31","value":-4.17,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":50.26,"profit":true},{"date":"2022-12-31","value":-19.25,"profit":false},{"date":"2023-12-31","value":14.86,"profit":true}]
Income After Taxes(30.00M)(72.27M)(104.39M)(85.88M)(70.91M)[{"date":"2019-12-31","value":-3000500000,"profit":false},{"date":"2020-12-31","value":-7227400000,"profit":false},{"date":"2021-12-31","value":-10439400000,"profit":false},{"date":"2022-12-31","value":-8587500000,"profit":false},{"date":"2023-12-31","value":-7091310500,"profit":false}]
Income From Continuous Operations(30.49M)(60.73M)(98.59M)(88.10M)(71.29M)[{"date":"2019-12-31","value":-3048700000,"profit":false},{"date":"2020-12-31","value":-6072800000,"profit":false},{"date":"2021-12-31","value":-9859100000,"profit":false},{"date":"2022-12-31","value":-8809800000,"profit":false},{"date":"2023-12-31","value":-7129100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(30.00M)(72.27M)(104.39M)(85.88M)(69.20M)[{"date":"2019-12-31","value":-3000500000,"profit":false},{"date":"2020-12-31","value":-7227400000,"profit":false},{"date":"2021-12-31","value":-10439400000,"profit":false},{"date":"2022-12-31","value":-8587500000,"profit":false},{"date":"2023-12-31","value":-6919700000,"profit":false}]
EPS (Diluted)(11.85)(19.43)(3.14)(2.36)(1.83)[{"date":"2019-12-31","value":-1185.2,"profit":false},{"date":"2020-12-31","value":-1942.57,"profit":false},{"date":"2021-12-31","value":-314,"profit":false},{"date":"2022-12-31","value":-236,"profit":false},{"date":"2023-12-31","value":-183,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BOLT
Cash Ratio 2.98
Current Ratio 3.16

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BOLT
ROA (LTM) -31.76%
ROE (LTM) -64.99%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BOLT
Debt Ratio Lower is generally better. Negative is bad. 0.34
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.66

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BOLT
Trailing PE NM
Forward PE NM
P/S (TTM) 1.71
P/B 0.23
Price/FCF NM
EV/R 270.65
EV/Ebitda 0.93

FAQs

What is Bolt Biotherapeutics share price today?

Bolt Biotherapeutics (BOLT) share price today is $0.412

Can Indians buy Bolt Biotherapeutics shares?

Yes, Indians can buy shares of Bolt Biotherapeutics (BOLT) on Vested. To buy Bolt Biotherapeutics from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BOLT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Bolt Biotherapeutics be purchased?

Yes, you can purchase fractional shares of Bolt Biotherapeutics (BOLT) via the Vested app. You can start investing in Bolt Biotherapeutics (BOLT) with a minimum investment of $1.

How to invest in Bolt Biotherapeutics shares from India?

You can invest in shares of Bolt Biotherapeutics (BOLT) via Vested in three simple steps:

  • Click on Sign Up or Invest in BOLT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Bolt Biotherapeutics shares
What is Bolt Biotherapeutics 52-week high and low stock price?

The 52-week high price of Bolt Biotherapeutics (BOLT) is $1.56. The 52-week low price of Bolt Biotherapeutics (BOLT) is $0.42.

What is Bolt Biotherapeutics price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Bolt Biotherapeutics (BOLT) is 0.23

What is the Market Cap of Bolt Biotherapeutics?

The market capitalization of Bolt Biotherapeutics (BOLT) is $16.19M

What is Bolt Biotherapeutics’s stock symbol?

The stock symbol (or ticker) of Bolt Biotherapeutics is BOLT

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top